Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Antiviral

Rwanda Accepts Favipiravir for Early Onset Mild COVID-19 Adding to a Growing List of Nations

The eastern African nation of Rwanda appears to be joining dozens of others nations worldwide and accepting Favipiravir as a […]

Rwanda Accepts Favipiravir for Early Onset Mild COVID-19 Adding to a Growing List of Nations`
4 weeks ago
Share

Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19

Appili Therapeutics Inc. (TSX: APLI, OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious […]

Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19
4 weeks ago
Share

University of Liverpool Led Preclinical Research Indicates Thapsigargin Powerful Antiviral Impact on SARS-CoV-2

Based on preclinical research in cell cultures and animals, a team of investigators at the University of Nottingham in England […]

University of Liverpool Led Preclinical Research Indicates Thapsigargin Powerful Antiviral Impact on SARS-CoV-2
1 month ago
Share

UCSF & Study Team: Drug Derived from a Sea Species 30X More Potent than Remdesivir Targeting SARS-CoV-2

A research team led by the prestigious University of California, San Francisco (UCSF) reveals that a drug known as Aplidin […]

UCSF & Study Team Drug Derived from a Sea Species 30X More Potent than Remdesivir Targeting SARS-CoV-2
1 month ago
Share

Rwanda Yet Another Country to Accept Favipiravir as a Repurposed Oral Treatment for COVID-19

Yet another nation has opted to embrace the antiviral drug Favipiravir (Avigan) as a treatment for early onset COVID-19.  Approved […]

Rwanda Yet Another Country to Accept Favipiravir as a Repurposed Oral Treatment for COVID-19
2 months ago
Share

University of Cincinnati Study Raises Questions Associated with Use of Remdesivir in COVID-19 Patients

A growing number of articles, papers and discussions point out that despite the great news of vaccines approved for emergency […]

Movement in Canada Grows for COVID-19 Therapies as Nation Awaits Health Canada Decision on Favipiravir
2 months ago
Share

Boom in Avifavir (Favipiravir) Demand to Treat COVID-19 Cases in Russia leads to Halt on All Exports

Russia’s Direct Investment Fund (RDIF), an active participant in funding the development of therapies and vaccines for that nation in […]

Boom in Avifavir (Favipiravir) Demand to Treat COVID-19 Cases in Russia leads to Halt on All Exports
2 months ago
Share

Will Favipiravir get Authorized in Japan for COVID-19? No Slam Dunk as Authorities Point to Inconclusive Data

Japanese health authorities are struggling to reach a decision as to whether favipiravir (Avigan) is effective as treatment for COVID-19 […]

Will Favipiravir get Authorized in Japan for COVID-19 No Slam Dunk as Authorities Point to Inconclusive Data
3 months ago
Share

Malaysian & Indian Academic Medical Centers Finds Favipiravir Relatively Safe & Somewhat Effective for COVID-19 Patients but More Research Necessary

A large group of researchers from Indian and Malaysian academic medical centers, led by Mainul Haque, Pharmacology Unit, Faculty of […]

Malaysian & Indian Academic Medical Centers Finds Favipiravir Relatively Safe & Somewhat Effective for COVID-19 Patents but More Research Necessary
3 months ago
Share

Kansas State University Virus Experts Continue Targeting Gaps in COVID-19 Research

Kansas State University College of Veterinary Medicine virologists are on a mission to fast track COVID-19 vaccines. But how well will […]

Kansas State University Virus Experts Continue Targeting Gaps in COVID-19 Research
3 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.